Church and Crawford Defines market of EMPS+ 8:00a ET

New Post Public Reply Private Reply Replies (0) Message Board
SuperC
Church and Crawford Defines market of EMPS+

8:00a ET February 21, 2012 (Business Wire)

Church & Crawford Inc. (OTC Pink: CCWF) has recently announced the addition of the global licence to use the technology and patents of the Orexis application. The mobile application has been developed for anyone who requires to talk to a service provider at any point, in essence Four Billion people globally.

The application provides direct cost reductions to Interactive Voice Recognition ("IVR") solutions (currently worth $413M USD), Computer Telephony Integration ("CTI") software (according to Frost & Sullivan is worth $7.86 billion) and Agent / HR reduction ($50 - $90 billion, varied reports). At the same time allows revenue generation via mobile marketing, according to Thompson Financial that's up to $21.31 billion.

Church & Crawford has secured the base technology and has a number of patents and enhancements to the platform in the pipeline. The end platform envisaged to be a customer contact application platform for mobile phones, which will be named End Point Mobile Solution+ ("EMPS+").

Once downloaded EMPS+ will allow user to navigate the graphical user interface ("GUI") to select options for self-service or to interact with the company via instant chat or voice. It provides for the first time ever the ability to turn cost centres into revenue centres, through the use of its advert engine, which provides real time, multimedia adverts displayed on the GUI.

EMPS+ instantly reduces costs in the areas of infra-structure, software and agents. The three key overheads for any operation. It can reduce these costs by up to 60% over a five year period, typically for a medium size contact centre that could translate up to $50M+ USD savings a year. By leveraging on data networks and cleverly managing customers interactions EMPS+ dramatically reduces the load on contact centres and the requirement for voice enabled agents.

The solution is handset, platform and industry agnostic, a first for any call centre solution.

The EMPS+ is the first ever CTI revenue generating platform, enabling companies to display advertisement on the GUI. Gartner research suggesting that the market was worth in the region of $14.6 billion in 2011 (global). Mobile advertisement is a very lucrative market. EMPS+ is the only mobile solution that provides advertisers "User Focused Space", i.e. complete and full attention of customer for up to 20 seconds whilst they wait for an agent.

For the user there are no adoption barriers and in fact is an enhancement to the customer experience. EMPS+ enables customers to interact in a much richer manner through the use of its innovative, simple GUI.

As EMPS+ is a complete end to end solution it also enables SME's that could not break the financial barrier to provide a contact centre solution to its customer the ability now to do so. With the use of agent chat sessions a SME cannot provide a top quality customer experience without having to pay top dollar.

The EMPS+ solution is simple. Yet its simplicity is its corner stone on producing a true WIN, WIN solution for companies and customers.

About Church & Crawford

Church & Crawford is a mobile phone software solutions company. The company develops and implements software solutions for mobile hand phones. Its main area of concentration is the development and implementation of software in these fields: Interactive Voice Response ("IVR") solutions, Computer Telephony Integration ("CTI") software.

Church & Crawford (CCWF) Stock Research Links

CCWF Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Intus Bio Secures $2.7M for Colorectal Cancer Test

Updated Category News Views 4

Pioneering Efforts in Early-Onset Colorectal Cancer Detection The battlefield of colorectal cancer prevention just got a serious upgrade with Intus Bio grabbing a $2.7 million award. This ain't just pocket change—it's a shot at rewriting the script on how we approach early-onset colorectal cancer, the pesky number one cancer gnawing at the under-50 crowd. Partnering...

Continue Reading
USFCR Wins 2026 Award for Federal Contracting Services

Updated Category News Views 7

Award-Winning Federal Contracting Strategies News from Clearwater, Florida: US Federal Contractor Registration (USFCR) just bagged the 2026 nod from Gov Business Review as the Federal Contracting Services of the Year. Now that's a feather in the cap worth talking about. This isn't some hallway compliment, folks. It's a signal that they've nailed how to get businesses...

Continue Reading
DCM Services Teams with AKUVO to Boost Estate Recoveries

Updated Category News Views 3

Revolutionizing Estate Recovery Practices Here's the scoop: DCM Services (DCMS), that big shot in estate account resolution, is hooking up with AKUVO to shake up how credit unions handle estate recoveries. This alliance is a clear nod to modernizing a process stuck in the past. Let’s face it, handling decedent and probate accounts is no cakewalk, and traditional methods...

Continue Reading
Modeling and Mental Health Join Forces for Wellness

Updated Category News Views 2

A Fresh Alliance for Mental Wellness in Modeling Alright, let's shine a spotlight on a significant step in the modeling industry, a place typically less vocal about mental health. In a move that feels long overdue, Brain-Body Therapy and Mother Model Management have joined forces, marking the beginning of a collaborative effort to propel mental wellness to the forefront...

Continue Reading
Flex Dental Solutions Adds BNPL, Surcharging to FlexPayments

Updated Category News Views 7

Diving into Dental Finances: A New Moneymaker? It's about time someone shook up the dental payment scene, and Flex Dental Solutions seems to be the one doing it. They rolled out some intriguing new features for their FlexPayments platform aimed squarely at dental practices using Open Dental. What we're seeing here is their attempt to bridge a couple of financial headaches...

Continue Reading
CrossCountry Mortgage Boosts Loan Limits, Flexibility for 2027

Updated Category News Views 28

Trailblazing in the Mortgage Game Well, what do we have here? CrossCountry Mortgage, the big cheese of retail mortgage lenders, is cranking up their conforming loan limits to a hefty $845,000. They're jumping the gun on the Federal Housing Finance Agency's official 2027 announcement. It's a classic move—proactive, bold, and a bit of a gamble, if you ask me. They’re...

Continue Reading
Veteran Marketer Joins The Wisory's Advisory Board

Updated Category News Views 5

Tyrrell Schmidt Joins The Wisory's Board Out of the blue, The Wisory has snatched Tyrrell Schmidt right off the retirement bench. This doesn't seem like just another board seating; it smells like a calculated power play. Schmidt, fresh from her heavyweight stint as Global CMO at TD Bank, adds a spicy dose of marketing prowess to The Wisory's already loaded Advisory Board....

Continue Reading
Melissa Rivers Brings Her Wit Back to Emmys Carpet

Updated Category News Views 5

They say you can never go home again, but don't tell that to Melissa Rivers. Rolling the dice on nostalgia and kicking off a new chapter, she's waltzing back to the Emmys red carpet for the first time in nearly 20 years. Alright, what's in it for investors? Not much—unless you're looking to invest in nostalgia. But there's something here about legacy, reinvention, and...

Continue Reading
Crystal Risotti: Leading IT Compliance in Healthcare

Updated Category News Views 6

A Journey Marked by Dedication and Expertise In the demanding world of healthcare technology, where regulations can make or break a company, Crystal Risotti has carved out a space for herself as a leader. Over the last 30 years, she's developed a reputation for blending regulatory expertise with practical business strategies. Her recognition as a Pinnacle Professional of...

Continue Reading
Seismic Pharma Kicks Off Phase 3 Trial for Istaroxime

Updated Category News Views 4

Seismic Sets the Stage for a Medical Milestone From the heart of biotech in Durham, North Carolina, seismic waves ripple through the medical community as Seismic Pharmaceuticals embarks on a high-stakes adventure. It's official: they've enrolled their very first patient in the global Phase 3 trial of istaroxime, targeting the grim specter known as cardiogenic shock. You...

Continue Reading

Top 5 Most Recently Viewed Articles

BioSig Technologies Updates on Merger and Share Issuance Plans

Updated Category News Views 169

BioSig Technologies Provides Merger Update LOS ANGELES and VANCOUVER, British Columbia — BioSig Technologies, Inc. (NASDAQ: BSGM), recently provided a significant update regarding its merger with Streamex Exchange Corporation. The recent developments aim to clarify the status of the merger and ensure all shareholders are informed. Details of the Merger Finalization The...

Continue Reading
Al Hurra Cuts Jobs and Merges Iraq Channel Amid Budget Cuts

Updated Category News Views 136

Al Hurra Faces Major Workforce Reductions The parent organization of the Arabic language broadcaster Al Hurra has announced significant layoffs, resulting in the elimination of 160 positions. This decision comes in the wake of a 20% budget cut mandated by the U.S. Congress, as revealed by the company’s CEO in a message to staff. Understanding the Budget Cuts Dr. Jeffrey...

Continue Reading
Strategies for Success in Hinge Research Institute's 2025 Study

Updated Category News Views 627

Innovative Strategies Highlighted in Hinge Research's 2025 Study Hinge Research Institute stands at the forefront of research on professional services growth. With its recent 10th Annual High Growth Study, the institute has delivered crucial insights into how successful firms thrive in today’s rapidly evolving market. The study not only illustrates the growth potential...

Continue Reading
Psyence Biomed Celebrates Milestones in Psilocybin Development

Updated Category News Views 125

Recent Developments in Psyence Biomed's Journey In a significant update shared by Psyence Biomedical Ltd. (Nasdaq: PBM), the company has showcased its achievements, reflecting a positive trajectory in the realm of psychedelic-based therapeutics. Highlights from the update included the impressive valuation of their stake in PsyLabs, strong clinical trial progress, and a...

Continue Reading
Rugby Resources Limited Expands Private Placement Offerings

Updated Category News Views 146

Rugby Resources Limited Expands Private Placement Opportunities Rugby Resources Ltd. (TSX-V: RUG) has announced an important development regarding its private placement offering. Responding to high subscriber demand, the company's board has authorized an increase in the number of available units, raising the offering from 60 million units to an impressive 81.84 million...

Continue Reading